1 domain / 2 areas / 1 specialization
Roth Capital
Data updated
Roth Capital Partners, LLC is a relationship-driven investment bank serving growth companies and their investors. It is headquartered in Newport Beach, California, with a global trading floor in Stamford, Connecticut.
ROTH’s healthcare platform provides financing and strategic advisory services for public and private life sciences companies, including IPOs, follow-on offerings, PIPEs, registered directs, and confidentially marketed public offerings. In the psychedelic ecosystem, that makes it relevant primarily as a capital markets and advisory participant rather than a dedicated psychedelic specialist.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Growth / Late Stage, Public Markets, and Multi-Stage. Public focus areas include Drug Development.
ROTH is an employee-owned investment bank centered on small-cap and growth-company capital markets, with broad institutional distribution and a stated healthcare/life sciences practice. Its public-facing relevance to psychedelics is indirect: it may appear in life sciences financings, public-market transactions, or conference activity, but its website does not indicate a specific public psychedelic focus.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Quick Facts
- Founded
- 1984
- HQ
- Newport Beach, California, United States
- Website
- Visit